Freshworks Inc vs 22nd Century Group Inc — how do they compare? Freshworks Inc trades at $10.87 (market cap $2.93B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Freshworks Inc is far larger — about 1927.6× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| FRSH | XXII | |
|---|---|---|
Market Cap | $2.93B | $1.52M |
Sector | Technology | Technology |
52-Week High | $14.77 | $1.47K |
52-Week Low | $6.88 | $3.90 |
Enterprise Value | $2.19B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $10.88, up 3.92% with a bullish technical signal and strong revenue growth from $720M in 2024 to $839M in 2025. The company achieved profitability in 2025 with net income of $184M, reversing prior losses. Recent news highlights AI product launches and a key partnership with Vanquis, while analyst consensus is split evenly between Buy and Hold ratings.
The outlook is positive with accelerating revenue and a path to sustained profitability, though high EV/EBITDA of 51.08 suggests premium valuation. Risks include execution on AI initiatives and competitive pressure in SaaS. Wall Street sees 26-38% upside potential based on price targets, making FRSH an attractive growth story if margins expand as projected.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →